47 min listen
Ep. 208.5: Part Two, Lateral Flow Technologies of Today and Tomorrow - Paul Davis
Ep. 208.5: Part Two, Lateral Flow Technologies of Today and Tomorrow - Paul Davis
ratings:
Length:
54 minutes
Released:
Sep 5, 2023
Format:
Podcast episode
Description
In Part Two of the Season 2 Finale of "Halteres Presents", Rich Thayer and Mickey Urdea continue their discussion with Paul Davis, dissecting the potential improvements to be made to today's lateral flow technologies, the possibilities (and realities) of what is yet to come with LFAs, and the best ways to build a team of inventors out of disparate personalities. Paul paints a detailed portrait of what "imagineering" can do to expand the scope and capabilities of lateral flow technologies, based on his trailblazing experiences in the field. Please enjoy Part Two of our interview with Paul Davis.
Paul Davis has worked in immunology for over 45 years and has founded or co-founded eight bioscience businesses since 2002, with Mologic being the most prominent. As Mologic’s chief scientific officer, Paul led the Centre for Advanced Rapid Diagnostics (CARD), funded by the Bill & Melinda Gates Foundation. Until 2002, he was as a senior scientist at Unilever Research leading applied immunology, and is one of the inventors of the lateral flow immunoassay.
Paul Davis has worked in immunology for over 45 years and has founded or co-founded eight bioscience businesses since 2002, with Mologic being the most prominent. As Mologic’s chief scientific officer, Paul led the Centre for Advanced Rapid Diagnostics (CARD), funded by the Bill & Melinda Gates Foundation. Until 2002, he was as a senior scientist at Unilever Research leading applied immunology, and is one of the inventors of the lateral flow immunoassay.
Released:
Sep 5, 2023
Format:
Podcast episode
Titles in the series (21)
Ep. 103: Global TB Diagnostics, Part 3 – Dr. Shibu Vijayan by Halteres Presents